Physician profile
Gerald E Atkins
NPI 1710165691
$1,788.55
in general payments reported to CMS, 2019-2025
11 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $489 · 2022: $398 · 2023: $126 · 2024: $535 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $445.45 | 2021-2023 | Xiaflex, Aveed |
| Rochester Medical Corporation | $326.75 | 2021-2022 | |
| Endo USA, INC. | $264.28 | 2024-2025 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $206.59 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Teleflex LLC | $152.11 | 2024 | Urolift |
| Sumitomo Pharma America, INC. | $140.35 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $102.10 | 2021 | |
| Abbvie INC. | $66.50 | 2021-2024 | |
| Axonics, INC. | $37.15 | 2021-2024 | Axonics |
| Janssen Biotech, INC. | $24.06 | 2021 | |
| Becton, Dickinson and Company | $23.21 | 2025 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Atkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.